37 participants
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-19
- Start Date:
- 2020-01-07
- Completion:
- 2023-03-31
Conditions
- Advanced Tumors
- Melanoma
- Non-Small-Cell Lung Cancer
- Erdheim-Chester Disease
- Other RAS/RAF/MEK/ERK Mutated Tumors
Interventions
- DRUG